Decipher Labs Ltd

Know More
Stock not tradded

18.22-0.16 (-0.87%)

04:01 PM,21st Feb 2024

BSE : 524752


Sector : Health care

ISIN Code : INE643N01012

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 21 2024 | 04:01 PM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)

Face Value


52-WK High


52-WK High Date

Invalid date

52-WK Low


52-WK Low Date

Invalid date

All Time High


All Time High Date

Invalid date

All Time Low


All Time Low Date

Invalid date

Decipher Labs Ltd

Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September 1986 and was converted into a Public Limited Company in Jun.'92. The company was promoted by Suchit Mohan Lal and Ajay Karan. The Company is a professionally managed well established diversified Public Limited Company engaged in the Manufacture & Marketing of Pharmaceuticals and allied products and services and providing Services and key Solutions in Information Technology Industry. Since inception the Company has been manufacturing & marketing its branded formulations and custom manufacturing for various companies besides supplies of various Bulk drugs chemicals and Finished Formulations. During the years of operations it has garnered a reputation as a quality provider in the Pharmaceutical industry and the Products marketed by the Company have been well accepted by the Trade and Medical Fraternity across India.?The Company also diversified interest in the field on Information Technology and has developed a name for itself as a key solution provider in the field of associated technologies. It expanded by reviving the Information Technology wing and started dealing and reviving its associations into the Information Technology Industry. To increase presence in the Information Technology segment the Company acquired Decipher Software Solutions LLC in USA to add good volumes to the overall turnover and Profits of the Company. The Company came out with a public issue of 23.23 lac equity shares at par aggregating Rs 2.32 cr in Nov.'94. The proceeds of the issue were utilised to part-finance a Rs 3.25-cr project to expand the existing manufacturing facilities for pharmaceutical formulations and to diversify into the manufacture of sterile powder injectables.CDL started commercial production in Jul.'87 on a loan-licence basis. The company acquired a full-fledged manufacturing unit located at Balanagar Hyderabad on lease from Fairchild Laboratories and commenced commercial production in Aug.'88. In Jul.'92 the manufacturing activities were shifted to the present leased premises at Kushaiguda Hyderabad. In this unit various pharmaceutical formulations such as tablets capsules and liquids are being manufactured. The product range of CDL comprises vital anti-bacterial drugs antibiotic drugs anti-inflammatory drugs haematenic drugs and protein tonic. CDL has developed in-house technology for the manufacture of dispersible and sustained release formulations. The company is exploring the possibilities of exporting its products to Nigeria and West Indies. During the year 1995-96 the expansion programme undertaken by the company was successfully completed and the unit at Yellampet has become operational.During 1996-97 the company has expanded its operations to new areas. It has expanded its product range by introduction of Liquid Orals. The product HB 2 has been well accepted in the market. The company has also filled its application for obtaining the (c)GMP and WHO GMP Certificate.

Decipher Labs Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]8.62
P/B Ratio (₹) [S]2.11
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week-2.10%%1.110.98%
1 Month-8.53%%1.682.24%
3 Month5.62%%10.1511.48%
6 Month15.68%%11.3613.72%
1 Year-10.90%%19.7023.72%
3 Year-44.62%%42.7147.21%

Company Info

Company Information

Executive Director : Sushant Mohan Lal

Independent Director : G Venkateswara Rao

Company Sec. & Compli. Officer : Megha Agarwal

Registered Office: 4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2,Hyderabad,Telangana-500034 Ph: